Amsterdam bans creation of new hotels
Another piece in the overall strategy to reduce tourist flows to the city
Belgian industrial biotech innovator Inbiose secures €15 million from EIB, Source: © Caroline Martin/EIB
Babies need these sugars to strengthen their immune system
The European Investment Bank (EIB) will provide 15 million euros of funding to Ghent-based biotech company Inbiose. The deal was signed on 14 July and the money is part of the 540-billion-euro rescue package in response to the COVID-19 pandemic.
The EIB wants to strengthen promising homegrown tech companies and Inbiose is a perfect candidate as they have found a way to imitate breast milk sugars that are not found in powdered milk.
At the beginning of this year, the federal government in Belgium drew up a list of projects vying for financing from the 5.95 billion euros allocated to Belgium from the European recovery fund. A significant portion of the money is invested in research and development, and this is where Inbiose comes in as one of the companies set to benefit.
They are a biotech SME based in Ghent’s Zwijnaarde’s technology park and are focused on a novel production process for the synthesis of human milk oligosaccharides (HMOs), functional sugars with a wide range of applications, primarily used in infant nutrition.
More than 100 different HMO structures are found in breast milk and Inbiose has found a way to produce six of them, and that is a big deal, as they are not found in powdered milk.
Generally, breast milk protects babies from infection and inflammation, helps the development of the immune system, promotes healthy bacteria in the gut and positively affects brain development. Babies who are not breastfed need these sugars, especially in the first three months, to strengthen their immune systems.
CEO of Inbiose Wim Soetaert explained that so far the company has copied six of these sugars and is hard at work on reproducing the rest, to make powdered milk resemble the real thing as much as possible.
The EIB’s financing will support Inbiose plans for heavy investments in R&D and production capacity, as they are one of the few companies capable of producing HMOs on a commercial scale.
If you want to keep up with how European cities and regions are changing, follow us on Facebook, Twitter and Instagram.
Another piece in the overall strategy to reduce tourist flows to the city
The previous mayor was forced out of office following a no-confidence vote in the city council
Modern traffic lights do more than regulate the flow of vehicles at crossroads, they also collect enormous amounts of data
The facility will replace the need to have water supplied by tankers from Valencia
Modern traffic lights do more than regulate the flow of vehicles at crossroads, they also collect enormous amounts of data
The German Aerospace Center in Cologne is looking for volunteers for its next bed rest study
Muksubussi is nature-friendly, too, so they provide 2-in-1 benefit
The facility will replace the need to have water supplied by tankers from Valencia
The intervention has affected the mountainous districts of the Catalan capital
Even an Eternal City had to start from somewhere
On this day 200 years ago, the great poet lost his life in the Balkan country where he had gone to fight for its liberty
Muksubussi is nature-friendly, too, so they provide 2-in-1 benefit
Urban dwellers across the EU are having a say in making their surroundings friendlier to people and the environment.
Forests in the EU can help green the European construction industry and bolster a continent-wide push for architectural improvements.
Apply by 10 November and do your part for the transformation of European public spaces
Catch up with some recommendations for the 2024 European Capital of Culture programme from the mayor of Tartu
An interview with the ICLEI regional director for Europe аfter the close of COP28
An interview with a member of the No Hate Speech Network team